Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/24376Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Driessen, J. H. M. | - |
| dc.contributor.author | Knapen, L. M. | - |
| dc.contributor.author | GEUSENS, Piet | - |
| dc.contributor.author | VAN DEN BERGH, Joop | - |
| dc.date.accessioned | 2017-09-06T10:45:19Z | - |
| dc.date.available | 2017-09-06T10:45:19Z | - |
| dc.date.issued | 2017 | - |
| dc.identifier.citation | OSTEOPOROSIS INTERNATIONAL, 28(8), p. 2429-2430 | - |
| dc.identifier.issn | 0937-941X | - |
| dc.identifier.uri | http://hdl.handle.net/1942/24376 | - |
| dc.language.iso | en | - |
| dc.publisher | SPRINGER LONDON LTD | - |
| dc.rights | © International Osteoporosis Foundation and National Osteoporosis Foundation 201 | - |
| dc.title | Fracture risk reduction with use of dipeptidyl peptidase-4 inhibitors: is there immortal time bias? | - |
| dc.type | Journal Contribution | - |
| dc.identifier.epage | 2430 | - |
| dc.identifier.issue | 8 | - |
| dc.identifier.spage | 2429 | - |
| dc.identifier.volume | 28 | - |
| local.format.pages | 2 | - |
| local.bibliographicCitation.jcat | A1 | - |
| dc.description.notes | [Driessen, J. H. M.; Knapen, L. M.] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Maastricht, Netherlands. [Driessen, J. H. M.; van den Bergh, J. P. W.] Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab, Maastricht, Netherlands. [Driessen, J. H. M.; Knapen, L. M.] Maastricht Univ, Med Ctr, Dept Clin Pharm & Toxicol, Maastricht, Netherlands. [Driessen, J. H. M.] Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands. [Geusens, P. P. M. M.; van den Bergh, J. P. W.] Hasselt Univ, Biomed Res Ctr, Agoralaan Gebouw D, B-3590 Diepenbeek, Belgium. [Geusens, P. P. M. M.; van den Bergh, J. P. W.] Maastricht Univ, Med Ctr, Dept Internal Med, Subdivis Rheumatol,CAPHRI, Maastricht, Netherlands. [van den Bergh, J. P. W.] VieCuri Med Ctr, Dept Internal Med, POB 1926, NL-5900 BX Venlo, Netherlands. | - |
| local.publisher.place | LONDON | - |
| local.type.refereed | Refereed | - |
| local.type.specified | Letter | - |
| dc.identifier.doi | 10.1007/s00198-017-4120-2 | - |
| dc.identifier.isi | 000406275400020 | - |
| item.contributor | Driessen, J. H. M. | - |
| item.contributor | Knapen, L. M. | - |
| item.contributor | GEUSENS, Piet | - |
| item.contributor | VAN DEN BERGH, Joop | - |
| item.fullcitation | Driessen, J. H. M.; Knapen, L. M.; GEUSENS, Piet & VAN DEN BERGH, Joop (2017) Fracture risk reduction with use of dipeptidyl peptidase-4 inhibitors: is there immortal time bias?. In: OSTEOPOROSIS INTERNATIONAL, 28(8), p. 2429-2430. | - |
| item.accessRights | Restricted Access | - |
| item.fulltext | With Fulltext | - |
| item.validation | ecoom 2018 | - |
| crisitem.journal.issn | 0937-941X | - |
| crisitem.journal.eissn | 1433-2965 | - |
| Appears in Collections: | Research publications | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| o.pdf Restricted Access | Published version | 276.51 kB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.